Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

pharmaphorum publishingpharmaphorum publishing
VS
Intas PharmaceuticalsIntas Pharmaceuticals
pharmaphorum publishing

pharmaphorum publishing

Rosemount Avenue, West Byfleet, KT14 6LB, GB

Last Update: 01/01/2026

View Profile
Between 750 and 799
https://pharmaphorum.com/
753/1000Fair

pharmaphorum.com, and its associated digital magazine Deep Dive, is a leading online destination for healthcare and pharmaceutical industry news, insight and debate. We deliver daily content and multimedia (e.g. video, webinars and podcasts) spanning every aspect of he...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:None
Subsidiaries:1
12-month incidents
0
Known data breaches
0
Attack type number
0
Intas Pharmaceuticals

Intas Pharmaceuticals

Sarkhej Gandhinagar Highway, Near Sola Bridge, Ahmedabad, Gujarat, IN

Last Update: 01/04/2026

View Profile
Between 750 and 799
https://intaspharma.com
795/1000Fair

Intas is one of the leading multinational pharmaceutical formulation development, manufacturing, and marketing organization in the world. It has been growing at 19% CAGR and crossed the $2.5 billion mark in the past financial year. The company has set up a network of su...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:18,773
Subsidiaries:1
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
pharmaphorum publishing

pharmaphorum publishing

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Intas Pharmaceuticals

Intas Pharmaceuticals

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for pharmaphorum publishing in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Intas Pharmaceuticals in 2026.

Incidents

Incident History - pharmaphorum publishing (X = Date, Y = Severity)

pharmaphorum publishing cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Intas Pharmaceuticals (X = Date, Y = Severity)

Intas Pharmaceuticals cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
pharmaphorum publishing

pharmaphorum publishing

Incidents
No explicit notable incidents reported.
Intas Pharmaceuticals

Intas Pharmaceuticals

Incidents
No explicit notable incidents reported.

FAQ

Between pharmaphorum publishing company and Intas Pharmaceuticals company, which one has the best AI Cybersecurity Score ?
Between pharmaphorum publishing company and Intas Pharmaceuticals company, which one has experienced more cyber incidents in the past ?
Between pharmaphorum publishing company and Intas Pharmaceuticals company, which one has experienced more cyber incidents this year ?
Between pharmaphorum publishing company and Intas Pharmaceuticals company, which one has experienced at least one ransomware attack ?
Between pharmaphorum publishing company and Intas Pharmaceuticals company, which one has experienced at least one data breach ?
Between pharmaphorum publishing company and Intas Pharmaceuticals company, which one has experienced at least one targeted cyberattack ?
Between pharmaphorum publishing company and Intas Pharmaceuticals company, which one has experienced at least one vulnerability ?
Between pharmaphorum publishing company and Intas Pharmaceuticals company, which one holds the most compliance certifications ?
Between pharmaphorum publishing company and Intas Pharmaceuticals company, which one holds the fewest compliance certifications ?
Between pharmaphorum publishing company and Intas Pharmaceuticals company, which one has the most subsidiaries ?
Between pharmaphorum publishing company and Intas Pharmaceuticals company, which one has the largest number of employees ?
Between pharmaphorum publishing and Intas Pharmaceuticals, which company holds both SOC 2 Type 1 certifications ?
Between pharmaphorum publishing and Intas Pharmaceuticals, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - pharmaphorum publishing or Intas Pharmaceuticals ?
Which company is PCI DSS compliant - pharmaphorum publishing or Intas Pharmaceuticals ?
Between pharmaphorum publishing and Intas Pharmaceuticals, which company complies with HIPAA regulations for healthcare data ?
Between pharmaphorum publishing and Intas Pharmaceuticals, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-50044
SUMMARY

Pronetiqs IntraVUE versions 3.2.1a14 and prior have an inadequate encryption strength vulnerability which could allow an attacker to steal admin credentials via weak hash or a pass-the-hash attack.

PUBLISHED
Date2026-07-23
UPDATED
Date2026-07-23
RISK INFORMATION (Score: 6.8)
CVSS3
Base Score: 6.8
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:H/I:H/A:N
CVSS4
Base Score: 7.6
Complexity: HIGH
CVSS:4.0/AV:N/AC:H/AT:P/PR:L/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.2
EXPLOITABILITY
1.6
CVE-2026-44955
SUMMARY

Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could allow for asset discovery by unauthenticated users.

PUBLISHED
Date2026-07-23
UPDATED
Date2026-07-23
RISK INFORMATION (Score: 5.3)
CVSS3
Base Score: 5.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N
CVSS4
Base Score: 6.9
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
1.4
EXPLOITABILITY
3.9
CVE-2026-42933
SUMMARY

Pronetiqs IntraVUE versions 3.2.1a14 and prior have an unintended proxy or intermediary vulnerability which could allow an attacker to use an active proxy, which would bypass OT segmentation.

PUBLISHED
Date2026-07-23
UPDATED
Date2026-07-23
RISK INFORMATION (Score: 10)
CVSS3
Base Score: 10.0
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H
CVSS4
Base Score: 10.0
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
6
EXPLOITABILITY
3.9
CVE-2026-40430
SUMMARY

Pronetiqs IntraVUE Versions 3.2.1a14 and prior have a plaintext storage of a password vulnerability that could expose cleartext credentials through the API.

PUBLISHED
Date2026-07-23
UPDATED
Date2026-07-23
RISK INFORMATION (Score: 7.5)
CVSS3
Base Score: 7.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
CVSS4
Base Score: 8.7
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.6
EXPLOITABILITY
3.9
CVE-2026-28698
SUMMARY

Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could expose the underlying host/share filesystem.

PUBLISHED
Date2026-07-23
UPDATED
Date2026-07-23
RISK INFORMATION (Score: 8.6)
CVSS3
Base Score: 8.6
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:N/A:N
CVSS4
Base Score: 9.2
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:H/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
4
EXPLOITABILITY
3.9